References
- Michelson S, Leith J T, Glicksman AS. A technique to analyse the emerging zonality of heterogenous solid tumors. Cell Tissue Kinet 1987; 20: 449–506
- Michelson S, Leith JT. Unexpected equilibria resulting from differing growth rates of sub populations within heterogeneous tumours. Mathemat Biosc 1988; 91: 119–29
- Predictive drug testing on human tumour cells, V Hofmann, M E Berens, G Martz. Springer-Verlag, Berlin, Heidelberg, New York, Tokyo 1984
- Peters LJ. Inherent radiosensitivity of tumour and normal tissue cells as a predictor of human tumour response. Radiother Oncol 1990; 17: 177–90
- Steel G G, Peacock JH. Why are some human tumours more radiosensitive than others?. Radiother Oncol 1989; 15: 63–72
- Fertil B, Malaise EP. Inherent cellular radiosensitivity as a basic concept for human tumour radiotherapy. Int J Radiat Oncol Biol Phys 1981; 7: 621–9
- Steel G G, Courtenay V D, Peckham MJ. The response to chemotherapy of a variety of human tumour xenografts. Br J Cancer 1983; 47: 1–13
- Hamburger A W, Salmon SE. Primary bioassay of human tumour stem cells. Science 1977; 197: 461–3
- Courtney VD. A replenishable soft agar colony assay for human tumour sensitiveity testing. Predictive drug testing on human tumour cells, Hofmann, Berens, Martz. Springer-Verlag, Berlin, Heidelberg, New York, Tokyo 1984; 17–34
- Puck T T, Marcus PI. Action of x-rays on mammalian cells. J Exp Med 1956; 103: 653–66
- Sanfilippo O, Daidone M G, Costa A, Canetta R, Silvestrini R. Estimation of differential in vitro sensitivity of non-Hodgkin's lymphomas to anticancer drugs. Eur J Cancer 1981; 17: 217–26
- Volm M, Waiss K, Kaufmann M, Mattern J. Pretherapeutic detection of tumour resistance and the results of tumour chemotherapy. Eur J Cancer 1979; 15: 983–93
- Weisenthal L M, Marsden J A, Dill P L, Macaluso CK. A novel dye exclusion method for tesing in vitro chemosensitivity of human tumours. Cancer Res 1983; 43: 749–54
- Freshney R I, Hart E. Clonogenicity of human glia in suspension. Br J Cancer 1982; 46: 463–70
- Laug WE, Tokes Z A, Benedict W F, Sorgente N. Anchorage independent growth and plasimogen activator production by bovine endothelial cells. J Cell Biol 1980; 84: 281–93
- Mothersill C, Cusack A, Seymour CB. Radiation induced outgrowth inhibition in explant cultures from surgical speciments of five human organs. Br J Radiol 1988; 61: 226–30
- Mothersill C, Seymour C B, Bonnar J. Effect of radiation and other cytotoxic agents on the growth of cells cultured from normal and tumour tissues from the female genital tract. Gynaecol Oncol 1990; 37: 210–8
- Seymour C B, Mothersill C, Cusack A, Hennessy TP. The effect of radiation on the growth of normal and malignant human oesophageal explant cultures pretreated with bleomycin. Br J Radiol 1988; 61: 1988, 383–7
- Gerdes J, Schwab U, Lembe H, Stein BH. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983; 31: 1983, 13–20
- Mothersill C, Cusack A, Mac Donnell M, Hennessy TP, Seymour CB. Differential response of normal and tumour oesophageal explant cultures to radiation. Acta Oncol 1988; 27: 275–80
- Duchesne G M, Peacock JH. Radiation cell survival and growth delay studies in multicellular spheroids of small-cell ling carcinoma. Int J Radiat Biol 1987; 51: 365–75
- Seymour C B, Mothersill C, Alper T. High yields of lethal mutations in somatic mammalian cells that survive ionising radiation. Int J Radiat Biol 1986; 53: 319–30
- Mendonca M S, Kurohara W, Antoniono R, Redpath JL. Plating efficiency as a function of time post-irradiation. Evidence for the delayed expression of lethal mutations. Radiat Res 1989; 119: 387–93
- Rozencweig M, Hofmann V, Sanders C, Rombaut W, Fruch U, Martz G. In vitro growth of human malignancies in a cloning assay in predictive drug testing on human tumour cells Hofmann, Berens, Martz. Springer-Verlag, Berlin, Heidelberg, New York, Tokyo 1984; 1–7
- Goldie J H, Coldman AJ. A mathematic model for relating the drug sensitivity of tumours to their spontaneous mutation rate. Cancer Treat Rep 1979; 63: 1727–31
- Dexter D L, Leith JT. Tumour heterogeneity and drug resistance. J Clin Oncol 1986; 4: 244–57